Increasing clonality of hematopoietic cells resulting from an accumulation of somatic mutations can lead to disease progression, where CHIP progresses to MDS for example, which can in turn transform to AML (associated with a poorer prognosis). This evidence concerns the gene STUB1 and myelodysplastic syndrome.